![<?echo $_SERVER['SERVER_NAME'];?>](/template/twentyseventeen/skin/images/header.jpg)
In view of the rapidly increasing trend of global adolescent diabetes patients, U.S. scientists said in Beijing on May 13 that using artificial intelligence pump therapy to monitor and supplement insulin dynamically will be an important therapy for adolescent diabetes.
Steven Wetteling, director of diabetes and metabolism at the University of Rochester, said in a speech at the Peking University Diabetes Forum in 2007 that adolescents with diabetes are more likely to have accurate controls on diets and lifestyle habits due to their greater mood swings, The dose of insulin has always been a medical problem. Using the latest insulin pump technology, blood glucose levels can be accurately monitored at every moment, and the right amount of insulin at the right time.
In his report titled "New Advances in Insulin Pump Therapy," Wetteling said the basic technique for pump therapy is to monitor blood glucose levels dynamically. The subcutaneous probe inserted into the patient can chemically react with glucose in the interstitial fluid to generate an electrical signal. After being processed by the computer system, the blood glucose profile of the patient can be obtained. According to the doctor's blood glucose changes, the injection procedure can be set so that the insulin pump carried by the patient injects a specific dose at a specific time.
According to reports, insulin pump has come out nearly 30 years. In 1978, the first insulin pump developed by Medtronic in the United States was as large as a march bag, and patients had to shoulder their shoulders. Today, insulin pumps have been as small as pagers. At present, some companies in the United States have invested heavily in the development of this technology. Insulin pumps under development by companies such as Medtronic can automatically input insulin according to feedback from blood glucose sensors without human intervention. This will make the insulin pump play the role of artificial pancreas.
According to statistics, nearly 1.1 million people died of diabetes in 2005 in the world.
Steven Wetteling, director of diabetes and metabolism at the University of Rochester, said in a speech at the Peking University Diabetes Forum in 2007 that adolescents with diabetes are more likely to have accurate controls on diets and lifestyle habits due to their greater mood swings, The dose of insulin has always been a medical problem. Using the latest insulin pump technology, blood glucose levels can be accurately monitored at every moment, and the right amount of insulin at the right time.
In his report titled "New Advances in Insulin Pump Therapy," Wetteling said the basic technique for pump therapy is to monitor blood glucose levels dynamically. The subcutaneous probe inserted into the patient can chemically react with glucose in the interstitial fluid to generate an electrical signal. After being processed by the computer system, the blood glucose profile of the patient can be obtained. According to the doctor's blood glucose changes, the injection procedure can be set so that the insulin pump carried by the patient injects a specific dose at a specific time.
According to reports, insulin pump has come out nearly 30 years. In 1978, the first insulin pump developed by Medtronic in the United States was as large as a march bag, and patients had to shoulder their shoulders. Today, insulin pumps have been as small as pagers. At present, some companies in the United States have invested heavily in the development of this technology. Insulin pumps under development by companies such as Medtronic can automatically input insulin according to feedback from blood glucose sensors without human intervention. This will make the insulin pump play the role of artificial pancreas.
According to statistics, nearly 1.1 million people died of diabetes in 2005 in the world.